Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
CU-WCGS Linkage Program Summer Undergraduate Research Toggle Summer Undergraduate Research menu options ACCESS Summer Internship Program Pre-Doctoral Institutional Training Programs Student Experience Toggle Student Experience menu options Alumni Contact Information Form Student Services Toggle Student Services menu options Student Government (GSEC) Toggle Student Government (GSEC) menu options Board Games Club Student Services and Wellbeing Resources Hub Thesis & Dissertation: Guidelines for Masters and PhD Programs WCGS Positive Learning Environment & Student Mistreatment Policy Access and Belonging Toggle Access and Belonging menu options Weill Cornell IMSD Program ACCESS Summer Internship Program Esprit de Corps Student Clubs and Initiatives Toggle Student Clubs and Initiatives menu op
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
Basal cell of origin resolves neuroendocrine–tuft lineage plasticity in cancer
Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304.
The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse Models
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
Automated real-world data integration improves cancer outcome prediction
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancer
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies
Chromothripsis-Mediated Small Cell Lung Carcinoma
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study
Lung cancer research and treatment: global perspectives and strategic calls to action
Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small-Cell Lung Cancer
SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing
Small cell lung cancer profiling: an updated synthesis of subtypes, vulnerabilities, and plasticity
Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation
A Lung Cancer Mouse Model Database
IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
Genomic mapping of metastatic organotropism in lung adenocarcinoma
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation
Alveolar Differentiation Drives Resistance to <i>KRAS</i> Inhibition in Lung Adenocarcinoma
Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies